Cubist Systematic Strategies, LLC Enochian Biosciences Inc Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	N/A	19,994 New	19,994 $91,000
Q3 2023 Nov 14, 2023	BUY	$0.0 - $4.46 $0 - $48,618	10,901 New	10,901 $48,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $25,263 - $114,275	13,090 Added 101.47%	25,990 $50,000
Q1 2022 May 16, 2022	SELL	$4.42 - $9.0 $91,489 - $186,291	-20,699 Reduced 61.61%	12,900 $106,000
Q4 2021 Feb 14, 2022	BUY	$6.71 - $12.55 $15,332 - $28,676	2,285 Added 7.3%	33,599 $245,000
Q3 2021 Nov 15, 2021	BUY	$4.56 - $7.88 $142,791 - $246,754	31,314 New	31,314 $211,000

14.7M

24K

19.1K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.